Genetic testing for the clinician in prostate cancer


Por: Lopez-Campos, F, Linares-Espinos, E, Pijoan, XM, Pardo, GS, Morgan, TM, Martinez-Ballesteros, C, Martinez-Salamanca, J, Counago, F

Publicada: 1 oct 2020 Ahead of Print: 1 oct 2020
Resumen:
Introduction Prostate cancer (PCa) is one of the most common cancers worldwide and a leading cause of cancer-related mortality. Although the diagnosis and treatment of prostate cancer has improved substantially in recent years, new molecular biomarkers are needed to further prolong survival and improve the quality of life in these patients. Areas covered This review analyzes the current evidence for prognostic and predictive molecular biomarkers that can be applied across different clinical scenarios, ranging from localized disease to metastatic castration-resistant PCa, with a particular emphasis on the biomarkers likely to become available in routine clinical practice in the near future. Expert opinion There is a growing need for molecular testing to identify the most indolent types of prostate cancer to help optimize treatment strategies and spare treatment in these patients when possible. Current trends in the treatment of prostate cancer underscore the unmet clinical need for biomarkers to improve decision-making in a challenging clinical setting.

Filiaciones:
Lopez-Campos, F:
 Hosp Univ Ramon y Cajal, Radiat Oncol Dept, Madrid, Spain

Linares-Espinos, E:
 Hosp Univ La Paz, Urol Dept, Madrid, Spain

 Lyx Inst Urol, Urol Dept, Madrid, Spain

 Francisco De Vitoria Univ, Urol Dept, Madrid, Spain

Pijoan, XM:
 Hosp Univ Vall dHebron, Radiat Oncol Dept, Barcelona, Spain

Pardo, GS:
 Hosp Santa Creu & Sant Pau, Radiat Oncol Dept, Barcelona, Spain

Morgan, TM:
 Michigan Ctr Translat Pathol, Urol Dept, Ctr Comprehens Canc, Ctr Canc, Floor B1 Recept C, Ann Arbor, MI USA

Martinez-Ballesteros, C:
 Lyx Inst Urol, Urol Dept, Madrid, Spain

 Hosp Univ Puerta De Hierro Majadahonda, Urol Dept, Majadahonda 28222, Spain

Martinez-Salamanca, J:
 Lyx Inst Urol, Urol Dept, Madrid, Spain

 Francisco De Vitoria Univ, Urol Dept, Madrid, Spain

 Hosp Univ Puerta De Hierro Majadahonda, Urol Dept, Majadahonda 28222, Spain

Counago, F:
 Hosp Univ Quiron Salud Madrid, Radiat Oncol Dept, Madrid, Spain

 Hosp La Luz, Madrid, Spain

 Univ Europea Madrid, Madrid, Spain
ISSN: 14737159





EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Editorial
TAYLOR & FRANCIS AS, KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY, Reino Unido
Tipo de documento: Review
Volumen: 20 Número: 9
Páginas: 933-946
WOS Id: 000577631500001
ID de PubMed: 32885704

MÉTRICAS